Glesatinib
Product Specifications
CAS Number
936694-12-1
Synonyms
MGCD265
SKU
C01629-5mg
Target
C-Met
Applications
Protein Tyrosine Kinase
Additionnal Information
Glesatinib (MGCD265) is an orally bioavailable potent dual inhibitor of c-MET and SMO. Glesatinib counteracts P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) .
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP2-59363UV 100 µL
Mouse Monoclonal Hexanoyl-Lysine adduct Antibody (5E8) [DyLight 350]
Ask
View Details 
029634-APC 100 µL
UBCH9 (Ubiquitin-conjugating Enzyme E2 E3, Ubiquitin-protein Ligase E3, Ubiquitin Carrier Protein E3, Ubiquitin-conjugating Enzyme E2-23kD, UbcH9, UBE2E3, UBCE4) (APC) discontinued
Ask
View Details 